Titan Company Ltd

- The transcript on page 19 and surrounding pages does not mention any current or planned fundraising through debt or equity. - No announcements or discussions about new debt issuance or equity raises were made during the call. - The company appears focused on executing growth strategies across segments like EyeCare, Taneira, perfumes, and international business. - The management did not indicate any need for additional capital infusion for the next quarters. - Emphasis was on organic growth, operational performance, and margin improvements rather than fundraising. - Any future fundraising plans, if any, have not been disclosed in this earnings call or accompanying remarks.

- EyeCare: Continuing full execution of strategy started 8-9 months ago; building a solid growth foundation with exceptional product value across affordable fashion, progressive lenses, and premium frames. - Taneira (Ethnic Wear): Strengthening foundation with expectations for FY26 to be a blockbuster year; aiming to establish a prominent and respected brand in the ethnic wear industry. - Perfumes: Expansion underway with the first IRTH exclusive brand outlet launched in October at Palladium Mall, Mumbai; expecting rapid rollout across the country leveraging omni-channel potential. - International Business: Opening stores as per plan with strong customer response; growth momentum continues. - Engineering Business (TEAL): Performing well, contributing positively to portfolio. Overall, Titan Company is actively investing across emerging businesses to drive growth and brand positioning over the coming years.

- EyeCare segment: Strategy launched 8-9 months ago is delivering strong customer acquisition and growth, expected to continue building over many quarters. - Taneira (ethnic wear): Foundation strengthening with a target for FY26 to be a “blockbuster year” and to become a prominent name in the ethnic wear industry. - Perfumes (IRTH brand): Doing very well with plans to expand exclusive brand outlets, starting with Palladium Mall in Mumbai, aiming for nationwide growth. - International business: Continues strong with planned store openings and exceptional customer response. - Engineering business (TEAL): Performing well. - Jewellery business: Sustained early double-digit buyer growth, especially in studded and sub-₹1 lakh segments; CaratLane and Mia are growing rapidly. - Watches (analog segment): Strong premiumization and innovation-driven growth expected to continue for many years.

- Titan EyeCare: Strategy begun 8-9 months ago continues strongly with satisfying customer acquisition; growth foundation solid for coming quarters. - Taneira: Foundations strengthen; FY26 expected to be a "blockbuster year," aiming for prominence in ethnic wear. - Perfumes (IRTH): First exclusive store launched; significant expansion planned nationwide. - International Business: Continuing strong growth with stores opening as planned and gaining customer acclaim. - Engineering business (TEAL): Performing well, contributing positively to portfolio. - Jewellery EBIT Margin: Expected steady state at 11%-11.5% for FY25 with potential improvement in H2; long-term margin guidance remains around 11.5%-12.5%. - Analog Watches: Strong product innovation and premiumization expected to sustain growth for years ahead. - Emerging Businesses: Currently in investment phase prioritizing growth; profitability expected to improve as scale increases. - Overall: Portfolio is in a very good place with confident outlook for growth and profitability improvements in upcoming quarters and FY26.

The transcript from the Titan Company Limited Q2 FY25 Earnings Call does not explicitly mention current or expected order book or pending orders. The discussion primarily focuses on: - Inventory loss due to customs duty impact (~₹280 crores, one-time). - Sustained demand momentum post-festive and wedding seasons. - Growth in jewellery business with focus on studded and gold categories. - Expansion of CaratLane stores and growth in sub-₹1 lakh segments. - Watch business focusing on premiumization and innovation. - No direct commentary on current order book or pending orders figures. Therefore, there is no disclosed data on current or expected order backlog or pending orders in this call.